Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Penumbra, Inc. stock logo
PEN
Penumbra
$232.32
-0.9%
$260.79
$148.00
$310.00
$8.97B0.47454,068 shs75,786 shs
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$58.00
+1.7%
$58.54
$47.04
$103.81
$3.19B1.07847,579 shs126,193 shs
Solventum Corporation stock logo
SOLV
Solventum
$73.30
+0.4%
$73.98
$49.64
$85.92
$12.68B0.551.10 million shs37,172 shs
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€25.31
-0.9%
€23.96
€17.12
€26.50
€7.66B0.55328,250 shs3,682 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Penumbra, Inc. stock logo
PEN
Penumbra
-0.93%-4.02%-10.13%-15.32%+19.03%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-1.67%-2.43%-5.56%+7.56%-18.23%
Solventum Corporation stock logo
SOLV
Solventum
-0.93%-1.75%-1.93%+10.23%+45.85%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
+0.23%+2.46%+7.10%+17.82%+17.08%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Penumbra, Inc. stock logo
PEN
Penumbra
4.75 of 5 stars
4.42.00.03.72.02.51.9
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
2.2013 of 5 stars
3.41.00.00.02.32.50.6
Solventum Corporation stock logo
SOLV
Solventum
0.7374 of 5 stars
2.12.00.00.02.80.00.0
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
1.3065 of 5 stars
0.03.00.80.02.10.01.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Penumbra, Inc. stock logo
PEN
Penumbra
2.88
Moderate Buy$305.0731.31% Upside
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
2.78
Moderate Buy$84.1345.04% Upside
Solventum Corporation stock logo
SOLV
Solventum
2.27
Hold$84.3815.12% Upside
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
2.86
Moderate BuyN/AN/A

Current Analyst Ratings Breakdown

Latest PRCT, SOLV, PEN, and STVN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/15/2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$71.00 ➝ $68.00
7/15/2025
Solventum Corporation stock logo
SOLV
Solventum
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$80.00 ➝ $103.00
7/9/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$320.00 ➝ $285.00
7/9/2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$70.00
7/7/2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform
7/1/2025
Solventum Corporation stock logo
SOLV
Solventum
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$90.00
6/30/2025
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
6/6/2025
Solventum Corporation stock logo
SOLV
Solventum
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSector Weight
5/19/2025
Solventum Corporation stock logo
SOLV
Solventum
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Overweight$78.00 ➝ $87.00
5/9/2025
Solventum Corporation stock logo
SOLV
Solventum
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$80.00 ➝ $78.00
4/30/2025
Solventum Corporation stock logo
SOLV
Solventum
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$84.00 ➝ $80.00
(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Penumbra, Inc. stock logo
PEN
Penumbra
$1.19B7.53$2.84 per share81.90$29.99 per share7.75
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$249.12M12.88N/AN/A$7.71 per share7.52
Solventum Corporation stock logo
SOLV
Solventum
$8.25B1.54$9.89 per share7.41$17.13 per share4.28
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€1.12B6.82€0.75 per share33.91€5.02 per share5.04
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Penumbra, Inc. stock logo
PEN
Penumbra
$14.01M$1.06218.5646.372.113.41%11.14%8.40%7/29/2025 (Estimated)
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$91.41M-$1.70N/AN/AN/A-36.20%-28.09%-20.02%7/30/2025 (Estimated)
Solventum Corporation stock logo
SOLV
Solventum
$478M$2.1633.9313.351.894.55%31.01%6.53%8/4/2025 (Estimated)
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€127.45M€0.5149.6343.642.4511.14%10.00%6.03%N/A

Latest PRCT, SOLV, PEN, and STVN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Solventum Corporation stock logo
SOLV
Solventum
$1.45N/AN/AN/AN/AN/A
8/7/2025Q2 2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$0.41N/AN/AN/AN/AN/A
7/29/2025Q2 2025
Penumbra, Inc. stock logo
PEN
Penumbra
$0.81N/AN/AN/A$327.37 millionN/A
5/8/2025Q1 2025
Solventum Corporation stock logo
SOLV
Solventum
$1.19$1.34+$0.15$0.78$2.02 billion$2.07 billion
4/24/2025Q1 2025
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$0.49-$0.45+$0.04-$0.45$65.39 million$69.16 million
4/23/2025Q1 2025
Penumbra, Inc. stock logo
PEN
Penumbra
$0.66$0.83+$0.17$1.00$315.72 million$324.14 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
N/AN/AN/AN/AN/A
Solventum Corporation stock logo
SOLV
Solventum
N/AN/AN/AN/AN/A
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/AN/AN/AN/A1 Years

Latest PRCT, SOLV, PEN, and STVN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/2/2025
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
annual€0.060.3%6/5/20256/5/20257/17/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Penumbra, Inc. stock logo
PEN
Penumbra
0.02
6.30
3.68
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
0.13
8.95
7.75
Solventum Corporation stock logo
SOLV
Solventum
2.40
1.19
0.85
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.22
1.83
1.26

Institutional Ownership

CompanyInstitutional Ownership
Penumbra, Inc. stock logo
PEN
Penumbra
88.88%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
89.46%
Solventum Corporation stock logo
SOLV
Solventum
N/A
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/A

Insider Ownership

CompanyInsider Ownership
Penumbra, Inc. stock logo
PEN
Penumbra
4.20%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
6.60%
Solventum Corporation stock logo
SOLV
Solventum
0.05%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Penumbra, Inc. stock logo
PEN
Penumbra
4,50038.73 million37.10 millionOptionable
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
43055.33 million51.68 millionOptionable
Solventum Corporation stock logo
SOLV
Solventum
22,000173.01 million172.93 millionOptionable
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
5,521302.84 million300.72 millionOptionable

Recent News About These Companies

Stevanato Group SpA (STVN) - Investing.com
STVN Stevanato Group S.p.A. - Seeking Alpha
Stevanato Group S.P.A. (IT0005452658.SG)
Stevanato: Recovery Underway, Buy Confirmed

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Penumbra stock logo

Penumbra NYSE:PEN

$232.32 -2.09 (-0.89%)
As of 10:47 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

PROCEPT BioRobotics stock logo

PROCEPT BioRobotics NASDAQ:PRCT

$58.00 +0.96 (+1.69%)
As of 10:47 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Solventum stock logo

Solventum NYSE:SOLV

$73.30 +0.27 (+0.36%)
As of 10:47 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

Stevanato Group stock logo

Stevanato Group NYSE:STVN

€25.31 -0.22 (-0.86%)
As of 10:22 AM Eastern

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.